Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
The C terminus of the human nicotinic alpha4beta2 receptor forms a binding site required for potentiation by an estrogenic steroid.
Paradiso K
,
Zhang J
,
Steinbach JH
.
???displayArticle.abstract???
In addition to actions mediated by changes in gene expression, steroids can directly modulate several transmitter-gated and voltage-gated ion channels. Despite numerous studies showing that steroids enhance or reduce ion channel activity, the site(s) that mediates steroid recognition is not known. To identify the regions in which steroids bind and affect ion channel activity, we have taken advantage of the observation that human alpha4beta2 neuronal nicotinic receptors are potentiated by an estrogen steroid, 17beta-estradiol, whereas a rat alpha4beta2 receptor is not. Mutations indicate that a sequence (AGMI) at the end of the C terminus of the human alpha4 subunit forms a binding site required for 17beta-estradiol potentiation. In contrast, ethynyl beta-estradiol (an oral contraceptive) potentiates both human and rat alpha4beta2 receptors. A single tryptophan in the C terminus of both the rat and the human alpha4 subunit is sufficient for potentiation by ethynyl beta-estradiol, probably through a pi-pi interaction. Mutation of this tryptophan eliminates the ability of ethynyl beta-estradiol to potentiate rat receptors. However, in human receptors it was necessary to mutate both the AGMI sequence and the tryptophan to eliminate potentiation by ethynyl beta-estradiol. The findings that beta-estradiol requires the AGMI sequence but that a single C-terminal tryptophan is sufficient for potentiation by ethynyl beta-estradiol indicate that the C terminus forms a binding site for these steroids. The binding site(s) for block appears to differ from those involved in potentiation because the C-terminal sequence does not affect block by steroids such as progesterone, and progesterone does not competitively inhibit potentiation.
Anand,
Nucleotide sequence of the human nicotinic acetylcholine receptor beta 2 subunit gene.
1990, Pubmed
Anand,
Nucleotide sequence of the human nicotinic acetylcholine receptor beta 2 subunit gene.
1990,
Pubmed
Anstead,
The estradiol pharmacophore: ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site.
1997,
Pubmed
Balthazart,
New insights into the regulation and function of brain estrogen synthase (aromatase).
1998,
Pubmed
Bertrand,
Steroids inhibit nicotinic acetylcholine receptors.
1991,
Pubmed
,
Xenbase
Blanton,
The steroid promegestone is a noncompetitive antagonist of the Torpedo nicotinic acetylcholine receptor that interacts with the lipid-protein interface.
1999,
Pubmed
,
Xenbase
Briggs,
Human alpha 7 nicotinic acetylcholine receptor responses to novel ligands.
1995,
Pubmed
,
Xenbase
Coggan,
Direct recording of nicotinic responses in presynaptic nerve terminals.
1997,
Pubmed
Deneris,
Primary structure and expression of beta 2: a novel subunit of neuronal nicotinic acetylcholine receptors.
1988,
Pubmed
,
Xenbase
DiPaola,
The sidedness of the COOH terminus of the acetylcholine receptor delta subunit.
1989,
Pubmed
Flores,
A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment.
1992,
Pubmed
Gray,
Hippocampal synaptic transmission enhanced by low concentrations of nicotine.
1996,
Pubmed
Hanstein,
Functional analysis of a novel estrogen receptor-beta isoform.
1999,
Pubmed
Kuiper,
Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta.
1997,
Pubmed
Kuryatov,
Mutation causing autosomal dominant nocturnal frontal lobe epilepsy alters Ca2+ permeability, conductance, and gating of human alpha4beta2 nicotinic acetylcholine receptors.
1997,
Pubmed
,
Xenbase
Lindstrom,
Nicotinic acetylcholine receptors in health and disease.
1997,
Pubmed
Marubio,
Reduced antinociception in mice lacking neuronal nicotinic receptor subunits.
1999,
Pubmed
McEwen,
Estrogen actions in the central nervous system.
1999,
Pubmed
McGehee,
Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors.
1995,
Pubmed
Moosmann,
The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties.
1999,
Pubmed
Paradiso,
Steroid inhibition of rat neuronal nicotinic alpha4beta2 receptors expressed in HEK 293 cells.
2000,
Pubmed
,
Xenbase
Park-Chung,
Distinct sites for inverse modulation of N-methyl-D-aspartate receptors by sulfated steroids.
1997,
Pubmed
,
Xenbase
Paterson,
Neuronal nicotinic receptors in the human brain.
2000,
Pubmed
,
Xenbase
Paul,
Neuroactive steroids.
1992,
Pubmed
Petersen,
Identification of estrogen receptor beta2, a functional variant of estrogen receptor beta expressed in normal rat tissues.
1998,
Pubmed
Rick,
Neurosteroids act on the GABA(A) receptor at sites on the N-terminal side of the middle of TM2.
1998,
Pubmed
Robel,
Neurosteroids: biosynthesis and function.
1995,
Pubmed
Rupprecht,
Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives.
1999,
Pubmed
Sabey,
Ligand binding and activation of rat nicotinic alpha4beta2 receptors stably expressed in HEK293 cells.
1999,
Pubmed
Stoffel-Wagner,
Expression of CYP19 (aromatase) mRNA in different areas of the human brain.
1999,
Pubmed
Sugaya,
Nicotinic acetylcholine receptor subtypes in human frontal cortex: changes in Alzheimer's disease.
1990,
Pubmed
Tanenbaum,
Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains.
1998,
Pubmed
Valera,
Progesterone modulates a neuronal nicotinic acetylcholine receptor.
1992,
Pubmed
,
Xenbase
Valverde,
Acute activation of Maxi-K channels (hSlo) by estradiol binding to the beta subunit.
1999,
Pubmed
,
Xenbase
Wevers,
Expression of nicotinic acetylcholine receptor subunits in the cerebral cortex in Alzheimer's disease: histotopographical correlation with amyloid plaques and hyperphosphorylated-tau protein.
1999,
Pubmed
Wiese,
Induction of the estrogen specific mitogenic response of MCF-7 cells by selected analogues of estradiol-17 beta: a 3D QSAR study.
1997,
Pubmed
Wonnacott,
Presynaptic nicotinic ACh receptors.
1997,
Pubmed
Zaman,
Effects of subunit types of the recombinant GABAA receptor on the response to a neurosteroid.
1992,
Pubmed
,
Xenbase